98 related articles for article (PubMed ID: 34167590)
21. Randomised comparative trial of the efficacy of paracetamol syrup and dispersible tablets for the treatment of fever in children.
Okereke B; Ibeleme O; Bisi-Onyemaechi A
J Int Med Res; 2021 Mar; 49(3):300060521999755. PubMed ID: 33736533
[TBL] [Abstract][Full Text] [Related]
22. Efficacy and safety of artemether-lumefantrine dispersible tablets compared with crushed commercial tablets in African infants and children with uncomplicated malaria: a randomised, single-blind, multicentre trial.
Abdulla S; Sagara I; Borrmann S; D'Alessandro U; González R; Hamel M; Ogutu B; Mårtensson A; Lyimo J; Maiga H; Sasi P; Nahum A; Bassat Q; Juma E; Otieno L; Björkman A; Beck HP; Andriano K; Cousin M; Lefèvre G; Ubben D; Premji Z
Lancet; 2008 Nov; 372(9652):1819-27. PubMed ID: 18926569
[TBL] [Abstract][Full Text] [Related]
23. Efficacy and safety of azithromycin 1 g once daily for 3 days in the treatment of community-acquired pneumonia: an open-label randomised comparison with amoxicillin-clavulanate 875/125 mg twice daily for 7 days.
Paris R; Confalonieri M; Dal Negro R; Ligia GP; Mos L; Todisco T; Rastelli V; Perna G; Cepparulo M
J Chemother; 2008 Feb; 20(1):77-86. PubMed ID: 18343748
[TBL] [Abstract][Full Text] [Related]
24. The efficacy and safety of amoxicillin-clavulanic acid 1000/125mg twice daily extended release (XR) tablet for the treatment of bacterial community-acquired pneumonia in adults.
Prabhudesai PP; Jain S; Keshvani A; Kulkarni KP
J Indian Med Assoc; 2011 Feb; 109(2):124-7. PubMed ID: 21888181
[TBL] [Abstract][Full Text] [Related]
25. Efficacy of high doses of penicillin versus amoxicillin in the treatment of uncomplicated community acquired pneumonia in adults. A non-inferiority controlled clinical trial.
Llor C; Pérez A; Carandell E; García-Sangenís A; Rezola J; Llorente M; Gestoso S; Bobé F; Román-Rodríguez M; Cots JM; Hernández S; Cortés J; Miravitlles M; Morros R
Aten Primaria; 2019 Jan; 51(1):32-39. PubMed ID: 29061311
[TBL] [Abstract][Full Text] [Related]
26. Effectiveness of discontinuing antibiotic treatment after three days versus eight days in mild to moderate-severe community acquired pneumonia: randomised, double blind study.
el Moussaoui R; de Borgie CA; van den Broek P; Hustinx WN; Bresser P; van den Berk GE; Poley JW; van den Berg B; Krouwels FH; Bonten MJ; Weenink C; Bossuyt PM; Speelman P; Opmeer BC; Prins JM
BMJ; 2006 Jun; 332(7554):1355. PubMed ID: 16763247
[TBL] [Abstract][Full Text] [Related]
27. Solid self-microemulsifying dispersible tablets of celastrol: formulation development, charaterization and bioavailability evaluation.
Qi X; Qin J; Ma N; Chou X; Wu Z
Int J Pharm; 2014 Sep; 472(1-2):40-7. PubMed ID: 24929011
[TBL] [Abstract][Full Text] [Related]
28. Promoting the integrated community case management of pneumonia in children under 5 years in Nigeria through the proprietary and patent medicine vendors: a cost-effectiveness analysis.
Okafor CE; Ekwunife OI; Nduaguba SO
Cost Eff Resour Alloc; 2021 Feb; 19(1):12. PubMed ID: 33632245
[TBL] [Abstract][Full Text] [Related]
29. Systematic review on antibiotic therapy for pneumonia in children between 2 and 59 months of age.
Lassi ZS; Das JK; Haider SW; Salam RA; Qazi SA; Bhutta ZA
Arch Dis Child; 2014 Jul; 99(7):687-93. PubMed ID: 24431417
[TBL] [Abstract][Full Text] [Related]
30. Antibiotic use for community-acquired pneumonia in neonates and children: WHO evidence review.
Mathur S; Fuchs A; Bielicki J; Van Den Anker J; Sharland M
Paediatr Int Child Health; 2018 Nov; 38(sup1):S66-S75. PubMed ID: 29790844
[TBL] [Abstract][Full Text] [Related]
31. Oral moxifloxacin vs high-dosage amoxicillin in the treatment of mild-to-moderate, community-acquired, suspected pneumococcal pneumonia in adults.
Petitpretz P; Arvis P; Marel M; Moita J; Urueta J;
Chest; 2001 Jan; 119(1):185-95. PubMed ID: 11157603
[TBL] [Abstract][Full Text] [Related]
32. The Influence of National Guidelines on the Management of Community-Acquired Pneumonia in Children. Do Pediatricians Follow the Recommendations?
Kraj G; Peradzyńska J; Chądzyńska J; Kulus M; Wołoszyn K; Jackowska T; Krajewska M; Mołdoch-Łukasik A; Czubik-Przybyła A; Górska-Kot A; Krenke K
Adv Exp Med Biol; 2019; 1211():103-110. PubMed ID: 31144241
[TBL] [Abstract][Full Text] [Related]
33. Effectiveness of early switch from intravenous to oral antibiotics in severe community acquired pneumonia: multicentre randomised trial.
Oosterheert JJ; Bonten MJ; Schneider MM; Buskens E; Lammers JW; Hustinx WM; Kramer MH; Prins JM; Slee PH; Kaasjager K; Hoepelman AI
BMJ; 2006 Dec; 333(7580):1193. PubMed ID: 17090560
[TBL] [Abstract][Full Text] [Related]
34. A comparison of cefditoren pivoxil and amoxicillin/ clavulanate in the treatment of community-acquired pneumonia: a multicenter, prospective, randomized, investigator-blinded, parallel-group study.
Fogarty CM; Cyganowski M; Palo WA; Hom RC; Craig WA
Clin Ther; 2002 Nov; 24(11):1854-70. PubMed ID: 12501879
[TBL] [Abstract][Full Text] [Related]
35. Ambulatory short-course high-dose oral amoxicillin for treatment of severe pneumonia in children: a randomised equivalency trial.
Hazir T; Fox LM; Nisar YB; Fox MP; Ashraf YP; MacLeod WB; Ramzan A; Maqbool S; Masood T; Hussain W; Murtaza A; Khawar N; Tariq P; Asghar R; Simon JL; Thea DM; Qazi SA;
Lancet; 2008 Jan; 371(9606):49-56. PubMed ID: 18177775
[TBL] [Abstract][Full Text] [Related]
36. Oral Antibiotics for Community acquired Pneumonia with Chest indrawing in Children Aged Below Five Years: A Systematic Review.
Lodha R; Randev S; Kabra SK
Indian Pediatr; 2016 Jun; 53(6):489-95. PubMed ID: 27376603
[TBL] [Abstract][Full Text] [Related]
37. The effect of food consumption on lumefantrine bioavailability in African children receiving artemether-lumefantrine crushed or dispersible tablets (Coartem) for acute uncomplicated Plasmodium falciparum malaria.
Borrmann S; Sallas WM; Machevo S; González R; Björkman A; Mårtensson A; Hamel M; Juma E; Peshu J; Ogutu B; Djimdé A; D'Alessandro U; Marrast AC; Lefèvre G; Kern SE
Trop Med Int Health; 2010 Apr; 15(4):434-41. PubMed ID: 20180933
[TBL] [Abstract][Full Text] [Related]
38. Efficacy of amoxicillin-sulbactam, given twice-a-day, for the treatment of community-acquired pneumonia: a clinical trial based on a pharmacodynamic model.
Jasovich A; Soutric J; Morera G; Mastruzzo M; Vesco E; Izaguirre M; Mobilia L; Prieto S; Franco D; Curcio D; Absi R; Larrateguy L; Bustos JL; Oliva ME; Arenoso H; Bantar C
J Chemother; 2002 Dec; 14(6):591-6. PubMed ID: 12583551
[TBL] [Abstract][Full Text] [Related]
39. Once-daily sparfloxacin versus high-dosage amoxicillin in the treatment of community-acquired, suspected pneumococcal pneumonia in adults. Sparfloxacin European Study Group.
Aubier M; Verster R; Regamey C; Geslin P; Vercken JB
Clin Infect Dis; 1998 Jun; 26(6):1312-20. PubMed ID: 9636854
[TBL] [Abstract][Full Text] [Related]
40. Clinical efficacy of 3 days versus 5 days of oral amoxicillin for treatment of childhood pneumonia: a multicentre double-blind trial.
Pakistan Multicentre Amoxycillin Short Course Therapy (MASCOT) pneumonia study group
Lancet; 2002 Sep; 360(9336):835-41. PubMed ID: 12243918
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
